US Stock Market Move | Reports say that the US government is considering withdrawing funding for the company's avian flu vaccine. Moderna (MRNA.US) fell more than 6%.

On Thursday, Moderna (MRNA.US) fell more than 6%, closing at $31.66. In news, it was reported that informed sources stated that the Trump administration is considering revoking funding for Moderna's avian flu vaccine, a contract worth about $590 million.